The Vaccine Trust Problem

To address the United States’ acute housing shortage, Congress recently passed a landmark piece of legislation designed to encourage the construction of new homes. The problem is that President Trump’s crackdown on immigration has taken aim at the work force required to build tho ...  Show more

The war in Iran has recently escalated in dangerous new ways, drawing in Bahrain, Kuwait and Saudi Arabia, as the Trump administration reeled from the Iranian killing of U.S. service members in Jordan. Eric Schmitt, a national security correspondent for The New York Times, discus ...  Show more

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ...  Show more

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more

It's been about a month since the first COVID-19 vaccines were approved in the United States. The goal was to vaccinate 20 million Americans by the end of 2020, but less than a quarter of them have actually received their first dose. Some public health officials are suggesting th ...  Show more

An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to ...  Show more